Cubilin activators represent a diverse collection of compounds able to stimulate cubilin gene expression. Despite variations in structure, these activators share the capacity to upregulate cubilin transcription. Many cubilin activators mediate their effects through receptor engagement on target cells. Binding induces receptor complex formation with cofactors that modify chromatin architecture near the cubilin promoter. These alterations improve access of basal transcriptional machinery. Some activators instead mobilize intracellular signaling networks, modifying activities of DNA-binding transcription regulators through post-translational changes.
Additionally, certain activators may influence broader cellular processes controlling cubilin expression levels. Perturbations to homeostatic mechanisms, stress responses, or epigenetic regulation can secondarily reshape the local transcriptional profile at the cubilin locus. Regardless of their specific mode of action, cubilin activators collectively serve to boost cubilin mRNA and protein production across tissue contexts. Elucidating their diverse stimulatory strategies has expanded insight into transcriptional governance of this endocytic receptor, with future work poised to provide new perspectives on normal regulation and pathological deregulation of cubilin.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II stimulates EGFR initiating MAPK cascades. This modifies ELK1 activity, enabling binding EBS sequences and increased cubilin transcription. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol induces SIRT1 activity, altering histone modifications at the cubilin locus to permit greater accessibility for transactivator proteins. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyric acid inhibits HDACs changing chromatin structure, enabling assembly of transcriptional initiation complexes over cubilin regulatory sequences. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 forms ER complexes recruiting factors remodeling cubilin promoter chromatin and enabling preinitiation complex formation to increase mRNA levels. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
VPA inhibits HDAC activity to alter histone-DNA interactions around the cubilin promoter favoring accessibility for regulatory proteins. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dex as a GR ligand induces dimerization enabling binding GRE motifs in the cubilin promoter, initiating its transcription. | ||||||